Solu-Cortef 250 mg/2mL (Hydrocortisone Sodium Succinate INJECTION, POWDER, FOR SOLUTION) 250 mg/2mL

Solu-Cortef 250 mg/2mL is a hydrocortisone sodium succinate injection used for hormone replacement and anti-inflammatory purposes. This powder for solution is administered intramuscularly or intravenously.

Strength

250 mg/2mL

Pack Size

25 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-0013-06) / 2 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Pharmacia & Upjohn Company LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Solu-Cortef is primarily used to replace cortisol in individuals with adrenal insufficiency. It may also be used to reduce inflammation in various conditions. Hydrocortisone sodium succinate is often prescribed for what is hydrocortisone used for, including adrenal crisis management and as an anti-inflammatory agent.

Side Effects

Common effects of Solu-Cortef may include temporary relief of inflammation and improved adrenal function. Some users may experience side effects such as increased appetite or changes in mood, though individual responses can vary.

Precautions & Warnings

Solu-Cortef should be handled with care, ensuring proper storage and administration by healthcare professionals. It is important to follow prescribed guidelines to minimize potential risks and ensure safe use.

Avoid Interactions

Solu-Cortef may interact with other medications, including those that affect the immune system or metabolism. It is advisable to consult a healthcare provider before combining it with other treatments, especially those involving alcohol or CYP inhibitors.

Frequently Asked Questions

Solu-Cortef is used for hormone replacement and reducing inflammation in conditions like adrenal insufficiency.

Solu-Cortef is administered either intramuscularly or intravenously after reconstitution.

Common side effects may include increased appetite, mood changes, and temporary relief of inflammation.

Solu-Cortef may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Solu-Cortef should be stored as per the manufacturer's guidelines to ensure its efficacy and safety.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.